Xometry 10-Q Details First GAAP Profit: Q3 Revenue $252.4M, Net Income $1.9M
XMTR has more than doubled off its 52-week low of $35.86 on elevated volume (3.4× avg).
Summary
Xometry's Q3 10-Q confirms the first meaningful GAAP profit — $1.9M net income on $252.4M revenue (up 40%) — with Adjusted EBITDA of $21.4M and $505.0M in cash and securities. Both convertible note series are now convertible at holders' option.
Key Events · Earnings and Guidance · XMTR
-
First GAAP Profit on 40% Growth
Q3 revenue of $252.4M rose 40% from $180.7M, producing $1.9M of net income versus an $11.6M loss a year earlier and $0.03 diluted EPS.
-
Operating Leverage Drives EBITDA
Adjusted EBITDA reached $21.4M, or 8.5% of revenue, versus $6.1M (3.4%) in Q3 2025; nine-month operating cash flow was $25.4M against $1.7M.
-
Liquidity of $505 Million
Cash and cash equivalents of $18.1M plus marketable securities of $486.9M totaled $505.0M at September 30, 2026, after the June equity raise and Siemens share sale.
-
Convertible Notes Now Convertible
Both sale-price triggers were met: 2027 noteholders could convert through October 30, 2026 and 2030 noteholders may convert during the quarter ending December 31, 2026; about 6.8M underlying shares sit in the diluted count.
Analysis · XMTR · Trade & Services
The real story here is operating leverage: Xometry's Q3 2026 10-Q puts hard numbers behind the same-day earnings release, showing revenue of $252.4M (up 40% from $180.7M), a swing to $1.9M of net income from an $11.6M loss, and $0.03 diluted EPS. Adjusted EBITDA reached $21.4M (8.5% of revenue) versus $6.1M a year ago, while nine-month operating cash flow came in at $25.4M against $1.7M. After the June equity raise and Siemens share sale, the balance sheet holds $505.0M of cash and marketable securities, so there is no near-term funding pressure. The offset is dilution already in motion: both convertible note series have met their sale-price triggers, meaning 2027 noteholders could convert through October 30, 2026 and 2030 noteholders can convert during the quarter ending December 31, 2026 — roughly 6.8M underlying shares sit in the diluted count.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XMTR was trading at $111.29 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $35.86 to $117.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.